60 likes | 100 Views
Get PDF Sample Of Research Report: https://goo.gl/auQndT<br>Global Metabolomics Market was valued at $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. Metabolomics is the study and analysis of the biochemical processes involving intermediates and byproducts of metabolic activities. These products are known as metabolomes, which reflect the cluster of all metabolites involved in various reactions in an organism, which include metabolic intermediates, signaling molecules, secondary metabolites, and hormones.<br>
E N D
Metabolomics Market Is Expected To Grow At a Lucrative Rate 2023 The biomarker discovery segment accounted for the highest market share in 2016, and is expected to continue this trend during the forecast period.
Intro Global Metabolomics Market was valued at $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. Metabolomics is the study and analysis of the biochemical processes involving intermediates and byproducts of metabolic activities.
Key Benefits Get PDF Sample Of Research Report: https://goo.gl/auQndT The report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. • Market estimations of the industry are provided based on the comprehensive analysis of the key developments in the industry. • In-depth analysis based on geography assists to understand the regional market and the strategic business planning. •
Metabolomics Market Key Segments: • Metabolomics Instruments • Separation Techniques • High-performance Liquid Chromatography • Gas Chromatography • Ultra-performance Liquid Chromatography • Capillary Electrophoresis. • Detection Techniques • Mass Spectrometry • Nuclear Magnetic Resonance Spectroscopy • Surface-based Mass Analysis • Metabolomics Bioinformatics Tools & Services • Bioinformatics Tools and Database • Bioinformatics Services
By Application Request For Customization: https://goo.gl/5BM9Mn •Biomarker Discovery •Drug Discovery •Toxicology Testing •Nutrigenomics •Functional Genomics •Personalized Medicine
List of players profiled in the report •Agilent Technologies, Inc., •Danaher Corporation, •Biocrates Life Sciences AG, •Bruker Corporation, •Leco Corporation, •Metabolon, Inc., •Human Metabolome Technologies, Inc., •Bio-Rad Laboratories, Inc., •Shimadzu Corporation, •Waters Corporation, and •Thermo Fisher Scientific Inc.